hemolytic anemia


Also found in: Thesaurus, Medical, Acronyms, Encyclopedia, Wikipedia.

hemolytic anemia

n.
Anemia resulting from the lysis of red blood cells, as in response to certain toxic or infectious agents and in certain inherited blood disorders.
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.hemolytic anemia - anemia resulting from destruction of erythrocytes
anemia, anaemia - a deficiency of red blood cells
Translations

he·mo·lyt·ic a·ne·mi·a

n. anemia hemolítica, anemia congénita causada por agentes tóxicos de eritrocitos frágiles de forma esferoidal.
References in periodicals archive ?
Hb H disease is typically a moderate hemolytic anemia associated with splenomegaly and bone changes.
Rituximab is an effective and safe therapeutic alternative in adults with refractory and severe autoimmune hemolytic anemia.
Use of the drug close to term may cause hemolytic anemia in newborns who are glucose-6-phosphate dehydrogenase (G6PD) deficient.
Acute hemolytic anemia may require administration of blood products, respiratory and hemodynamic support, or treatment of arrhythmias associated with hyperkalemia.
There are two types of autoimmune hemolytic anemia including cold-antibody hemolytic anemia and warm-antibody hemolytic anemia.
It is concluded that hemolytic anemia, liver and renal tubular damage impart significant clinico-pathological changes in hematology, serum biochemistry and mineral profile during equine leptospirosis.
To the extent of our knowledge, no case of extra-adrenal myelolipoma with accompanying hemolytic anemia has been reported.
In a patient with clinical and/or laboratory evidence of hemolysis and with the absence of an obvious inciting event (eg, transfusion), the presence of an autoimmune hemolytic anemia (AIHA) should be considered.
5] As an example, there have been several reports of patients presenting with neurologic symptoms without evidence of microangiopathic hemolytic anemia (MAHA) and thrombocytopenia who subsequently (within days to weeks) developed typical clinical features of TTP.
12] deficiency through a variety of mechanisms have surfaced in the setting of clinical syndromes of microangiopathic hemolytic anemia and thrombotic microangiopathy.
Food and Drug Administration (FDA) has granted Orphan Drug Designation for the True North Therapeutics's lead product candidate, TNT009 for the treatment of autoimmune hemolytic anemia, including Cold Agglutinin Disease (CAD), a form of autoimmune hemolytic anemia for which there are limited treatment options available for patients.